Page last updated: 2024-12-10

capsanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5281228
CHEMBL ID1519371
CHEBI ID3375
SCHEMBL ID117691
MeSH IDM0049708

Synonyms (46)

Synonym
unii-420ny1j57n
hsdb 7977
420ny1j57n ,
all trans capsanthin
SDCCGMLS-0066894.P001
capsanthin/capsorubin
3,3'-dihydroxy-beta,kappa-caroten-6'one
beta,kappa-caroten-6'one, 3,3'dihydroxy-
einecs 207-364-1
CHEBI:3375 ,
(3r,3's,5'r)-3,3'-dihydroxy-beta,kappa-caroten-6'-one
all-trans-capsanthin
LMPR01070265
UPCMLD-DP025:001
C08584
465-42-9
capsanthin ,
UPCMLD-DP025
NCGC00161603-01
SPECTRUM1505276
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-19-[(4r)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-19-(4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one
CHEMBL1519371
A827066
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-19-[(4r)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-4,8,13,17-tetramethyl-1-nonadeca-2,4,6,8,10,12,14,16,18-nonaenone
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethyl-19-[(4r)-2,6,6-trimethyl-4-oxidanyl-cyclohexen-1-yl]-1-[(1r,4s)-1,2,2-trimethyl-4-oxidanyl-cyclopentyl]nonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one
capsanthin/capsorubin [inci]
.beta.,.kappa.-caroten-6'one, 3,3'dihydroxy-
2,4,6,8,10,12,14,16,18-nonadecanonaen-1-one, 19-(4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-1-(4-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-, (all-e)-
(3r,3's,5'r)-3,3'-dihydroxy-.beta.,.kappa.-caroten-6'-one
capsanthin [mi]
3,3'-dihydroxy-.beta.,.kappa.-caroten-6'on
2,4,6,8,10,12,14,16,18-nonadecanonaen-1-one, 19-(4-hydroxy-2,6,6-trimethyl-1-cyclohexen-1-yl)-1-(5-hydroxy-1,2,2-trimethylcyclopentyl)-4,8,13,17-tetramethyl-
CCG-214238
SCHEMBL117691
capsanthin, >=90.0% (hplc)
SR-05000002758-1
sr-05000002758
DTXSID10905012 ,
Q425431
(2e,4e,6e,8e,10e,12e,14e,16e,18e)-1-((1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl)-19-((r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-4,8,13,17-tetramethylnonadeca-2,4,6,8,10,12,14,16,18-nonaen-1-one
HY-125711
CS-0093389
dtxcid401334125
3,3'-dihydroxy-beta,kappa-caroten-6'on
AKOS040761459

Research Excerpts

Overview

Capsanthin is an important metabolite in carotenoid metabolism. Its production level is closely linked to the expression of the genes for capsanthin/capsorubin synthase. Capsanthin has possible antitumor activity.

ExcerptReferenceRelevance
"Capsanthin is a natural red pigment widely used in the food industry, but its pigment is severely lost during use and storage. "( Inclusion complexes of capsanthin with acyclic cucurbit[n]urils to improve its stability and antioxidant capacity.
Li, Y; Liao, X; Liu, Q; Wang, L; Yang, B; Zhou, C; Zhou, J, 2024
)
3.2
"Capsanthin is an important metabolite in carotenoid metabolism, and its production level is closely linked to the expression of the genes for capsanthin/capsorubin synthase ("( Fast and High-Efficiency Synthesis of Capsanthin in Pepper by Transient Expression of Geminivirus.
Ali, MM; Lin, Z; Wang, S; Yi, X; Zhang, L, 2023
)
1.9
"Capsanthin is a naturally occurring red pepper carotenoid with possible antitumor activity, but its antitumor mechanisms have yet to be delineated. "( Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells.
Chien, YC; Huang, WC; Hung, CC; Liu, LC; Tsai, IC; Wu, JY; Yu, YL, 2021
)
3.51
"Capsanthin is a red carotenoid that gives mature pepper fruits their red color."( Effects of silencing key genes in the capsanthin biosynthetic pathway on fruit color of detached pepper fruits.
Chai, WG; Gong, ZH; Li, L; Shah, SN; Tian, SL, 2014
)
1.39

Actions

ExcerptReferenceRelevance
"Capsanthin was used because this carotenoid was not detected in the men's plasma before ingestion of paprika juice."( Accumulation and clearance of capsanthin in blood plasma after the ingestion of paprika juice in men.
Ishiguro, Y; Oshima, S; Sakamoto, H; Terao, J, 1997
)
1.31

Treatment

Capsanthin treatment significantly inhibited the expression of inflammatory cytokines, tumor necrosis factor-alpha (TNF-α), interleukins (IL-2, IL-4 and IL-6) and pro-inflammatory mediator, matrix metalloproteinase-9 (MMP9) Capsanthintreatment decreased catalase and glutathione levels but increased lipid peroxidation.

ExcerptReferenceRelevance
"Capsanthin treatment significantly inhibited the expression of inflammatory cytokines, tumor necrosis factor-alpha (TNF-α), interleukins (IL-2, IL-4, IL-6), and pro-inflammatory mediator, matrix metalloproteinase-9 (MMP9)."( Capsanthin from Capsicum annum fruits exerts anti-glaucoma, antioxidant, anti-inflammatory activity, and corneal pro-inflammatory cytokine gene expression in a benzalkonium chloride-induced rat dry eye model.
Shanmugham, V; Subban, R, 2022
)
2.89
"Capsanthin treatment decreased catalase and glutathione levels but increased lipid peroxidation."( Capsanthin Stimulates the Mitochondrial Apoptosis-Mediated Cell Death, following DNA Damage in MCF-7 Cells.
Erden, Y, 2021
)
2.79

Bioavailability

Capsanthin exhibits poor aqueous solubility, poor stability, and low oral bioavailability that limit its utility as a nutraceutical. The bioavailability of the pepper-specific carotenoids capsanthin and capsorubin from paprika oleoresin is very low.

ExcerptReferenceRelevance
"The pharmacokinetics of dietary capsanthin was measured in four male volunteers to assess the bioavailability of oxygenated carotenoids (xanthophylls)."( Accumulation and clearance of capsanthin in blood plasma after the ingestion of paprika juice in men.
Ishiguro, Y; Oshima, S; Sakamoto, H; Terao, J, 1997
)
0.87
" The bioavailability of the pepper-specific carotenoids capsanthin and capsorubin from paprika oleoresin is very low."( Incorporation of carotenoids from paprika oleoresin into human chylomicrons.
Martin, HD; Pérez-Gálvez, A; Sies, H; Stahl, W, 2003
)
0.57
" Although the provitamin A keto-carotenoids from sapote were highly bioaccessible, their qualitative and quantitative in vivo bioavailability and their conversion to vitamin A remains to be confirmed."( Deposition Form and Bioaccessibility of Keto-carotenoids from Mamey Sapote (Pouteria sapota), Red Bell Pepper (Capsicum annuum), and Sockeye Salmon (Oncorhynchus nerka) Filet.
Carle, R; Chacón-Ordóñez, T; Esquivel, P; Jiménez, VM; Schweiggert, RM, 2016
)
0.43
"Capsanthin, like other carotenoids, exhibits poor aqueous solubility, poor stability, and low/variable oral bioavailability that limit its utility as a nutraceutical."( Development of Nanoemulsion Preconcentrate of Capsanthin with Improved Chemical Stability.
Date, AA; Goge, N; Kulkarni, M, 2020
)
2.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (3 Product(s))

Product Categories

Product CategoryProducts
Other3

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carotenone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
capsanthin and capsorubin biosynthesis27

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency12.58930.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (4.35)18.7374
1990's4 (5.80)18.2507
2000's14 (20.29)29.6817
2010's32 (46.38)24.3611
2020's16 (23.19)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.28 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index85.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.39%)5.53%
Reviews5 (6.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]